Encapsulation of water insoluble drugs in mesoporous silica nanoparticles using supercritical carbon dioxide

46Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

Abstract

Mesoporous silica nanoparticles MCM - 41 were synthesized with two dimensional hexagonal p6mm symmetry, high specific surface area(~ 980m2/g) narrow pore size and an average particle size of 186 nm. The produced nanoparticles were used to encapsulate carbamazepine through a supercritical carbon dioxide process combined with various organic solvents. Supercritical processing was found to provide increased drug encapsulation. The loaded MCM - 41 nanoparticles were analyzed using X-ray diffraction and differential scanning calorimetry (DSC) to investigate the crystalline state of the encapsulated carbamazepine and it was found to be dependent on the nature of the organic solvent. Carbamazepine showed increased dissolution rates under sink conditions. Viability studies of Caco - 2 cells demonstrated negligible cytotoxicity for the MCM-41 nanoparticles. © 2011 Patil A, et al.

Cite

CITATION STYLE

APA

Patil, A., Chirmade, U. N., Trivedi, V., Lamprou, D. A., Urquhart, A., & Douroumis, D. (2011). Encapsulation of water insoluble drugs in mesoporous silica nanoparticles using supercritical carbon dioxide. Journal of Nanomedicine and Nanotechnology, 2(3). https://doi.org/10.4172/2157-7439.1000111

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free